Point32Health and GRAIL Expand Pilot Access to Multi-Cancer Early Detection Test
Point32Health and GRAIL announced the expansion of their pilot to offer GRAIL’s Galleri multi-cancer early detection screening test.
Read MorePosted by Andy Lundin | Sep 29, 2023 | Cancer |
Point32Health and GRAIL announced the expansion of their pilot to offer GRAIL’s Galleri multi-cancer early detection screening test.
Read MorePosted by Chris Wolski | Sep 19, 2023 | Cancer |
Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to...
Read MorePosted by Andy Lundin | Sep 7, 2023 | Cervical (HPV) |
New tests offer clinical and technological perspectives on how to measure if recurrence is happening earlier than current blood tests allow.
Read MorePosted by Andy Lundin | Aug 31, 2023 | Cancer |
Researchers are developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA “dark matter.”
Read MorePosted by Andy Lundin | Aug 17, 2023 | Cancer |
Americans have gotten at least 12 million more years of life to live due to preventive cancer screenings conducted over the past 25 years.
Read More